Клинико-генетические характеристики пациентов с хромосомными перестройками, сопровождающимися судорогами
https://doi.org/10.25557/2073-7998.2018.10.20-25
Аннотация
Об авторах
И. А. АкимоваРоссия
А. О. Боровиков
Россия
Список литературы
1. Lemke JR, Riesch E, Scheurenbrand T et al. Targeted next generation sequencing as a diagnostic tool in epileptic disorders. Epilepsia. 2012. 53(8): p. 1387-98.
2. Noebels JL. Single-Gene Determinants of Epilepsy Comorbidity. Cold Spring Harb Perspect Med. 2015. 5(11).
3. Oyrer J, Maljevic S, Scheffer IE et al. Ion Channels in Genetic Epilepsy: From Genes and Mechanisms to Disease-Targeted Therapies. Pharmacol Rev, 2018. 70(1): p. 142-173.
4. McTague A, Howell KB, Cross JH et al. The genetic landscape of the epileptic encephalopathies of infancy and childhood. Lancet Neurol. 2016. 15(3): p. 304-16.
5. Mefford HC, Yendle SC, Hsu C et al. Rare copy number variants are an important cause of epileptic encephalopathies. Ann Neurol. 2011. 70(6): p. 974-85.
6. Olson H, Shen Y, Avallone J et al. Copy number variation plays an important role in clinical epilepsy. Ann Neurol. 2014. 75(6): p. 943-58.
7. Zuberi SM, Chromosome disorders associated with epilepsy. Handb Clin Neurol. 2013. 111: p. 543-8.
8. Chugani H. Neuroimaging in Epilepsy. 2010.
9. MacDonald JR, Ziman R, Yuen RK et al. The Database of Genomic Variants: a curated collection of structural variation in the human genome. Nucleic Acids Res. 2014. 42(Database issue): p. D986-92
10. Huang N, Lee I, Marcotte EM et al. Characterising and predicting haploinsufficiency in the human genome. PLoS Genet. 2010. 6(10): p. e1001154.
11. Brunklaus A, Ellis R, Reavey E et al. Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome. Brain. 2012. 135(Pt 8): p. 2329-36.
12. Harkin LA, McMahon JM, Iona X et al. The spectrum of SCN1A-related infantile epileptic encephalopathies. Brain. 2007. 130(Pt 3): p. 843-52.
13. Bartnik M, Chun-Hui Tsai A, Xia Z et al. Disruption of the SCN2A and SCN3A genes in a patient with mental retardation, neurobehavioral and psychiatric abnormalities, and a history of infantile seizures. Clin Genet. 2011. 80(2): p. 191-5.
14. Celle ME, Cuoco C, Porta S et al. Interstitial 2q24.3 deletion including SCN2A and SCN3A genes in a patient with autistic features, psychomotor delay, microcephaly and no history of seizures. Gene, 2013. 532(2): p. 294-6.
15. Baasch AL, Huning I, Gilissen C et al. Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities. Epilepsia. 2014. 55(4): p. e25-9.
16. Wagenstaller J, Spranger S, Lorenz-Depiereux B et al. Copy-number variations measured by single-nucleotide-polymorphism oligonucleotide arrays in patients with mental retardation. Am J Hum Genet. 2007. 81(4): p. 768-79.
17. Talkowski ME, Mullegama SV, Rosenfeld JA et al. Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder. Am J Hum Genet. 2011. 89(4): p. 551-63.
18. Van Bon BW, Koolen DA, Brueton L et al. The 2q23.1 microdeletion syndrome: clinical and behavioural phenotype. Eur J Hum Genet. 2010. 18(2): p. 163-70.
19. Sorge G and Sorge A. Epilepsy and chromosomal abnormalities. Ital J Pediatr. 2010. 36: p. 36.
20. Battaglia A and Guerrini R. Chromosomal disorders associated with epilepsy. Epileptic Disord, 2005. 7(3): p. 181-92.
Рецензия
Для цитирования:
Акимова И.А., Боровиков А.О. Клинико-генетические характеристики пациентов с хромосомными перестройками, сопровождающимися судорогами. Медицинская генетика. 2018;17(10):20-25. https://doi.org/10.25557/2073-7998.2018.10.20-25
For citation:
Akimova I.A., Borovikov A.O. Clinical and genetic characteristics of patients with chromosomal rearrangements accompanied by seizures. Medical Genetics. 2018;17(10):20-25. (In Russ.) https://doi.org/10.25557/2073-7998.2018.10.20-25